The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer (Q48291586)

10 February 2018

title

The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer (English)

1 reference

10 February 2018

1 reference

1 reference

10 February 2018

author name string

Vladimir Djedovic

1 reference

10 February 2018

Yoo-Young Lee

1 reference

10 February 2018

Alexandra Kollara

1 reference

10 February 2018

Taymaa May

1 reference

10 February 2018

publication date

8 January 2018

1 reference

10 February 2018

published in

Hormones and Cancer

1 reference

10 February 2018

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Identification of ovarian cancer symptoms in health insurance claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Role of aggressive surgical cytoreduction in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Optimal primary surgical treatment for advanced epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Ovarian cancer: strategies for overcoming resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Minireview: Glucocorticoids in Autoimmunity: Unexpected Targets and Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

A naturally occurring insertion of a single amino acid rewires transcriptional regulation by glucocorticoid receptor isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid receptor control of transcription: precision and plasticity via allostery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoids and Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Negative regulation of SEK1 signaling by serum- and glucocorticoid-inducible protein kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Portrait of inflammatory response to ionizing radiation treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Membrane-derived second messenger regulates x-ray-mediated tumor necrosis factor alpha gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Pharmacokinetics and receptor-mediated pharmacodynamics of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Biochemical characterization of nuclear receptors for vitamin D3 and glucocorticoids in prostate stroma cell microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The influence of glucocorticoid signaling on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Integrin αvβ3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The cancer glycocalyx mechanically primes integrin-mediated growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Transforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid up-regulates transforming growth factor-beta (TGF-beta) type II receptor and enhances TGF-beta signaling in human prostate cancer PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Serum- and glucocorticoid-regulated kinase 1 is upregulated following unilateral ureteral obstruction causing epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid induces mesenchymal‐to‐epithelial transition and inhibits TGF‐β1‐induced epithelial‐to‐mesenchymal transition and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoids ameliorate TGF-β1-mediated epithelial-to-mesenchymal transition of airway epithelium through MAPK and Snail/Slug signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Rap1 signalling: adhering to new models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1/DAB2 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Stress and breast cancer: from epidemiology to molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

BRCA1 and implications for response to chemotherapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

The role of BRCA1 in the cellular response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemothe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-017-0319-0

Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study

21 January 2018

1 reference

12 December 2020

Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer

1 reference

12 December 2020

Steroid antiemesis may be harmful

1 reference

12 December 2020

Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer

1 reference

12 December 2020

Glucocorticoids inhibit apoptosis of human neutrophils

1 reference

12 December 2020

A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients

1 reference

12 December 2020

Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer

1 reference

12 December 2020

Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells.

1 reference

12 December 2020

Mechanisms of immunosuppression by glucocorticoids

1 reference

12 December 2020

Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells

1 reference

12 December 2020

Modulation of radiation damage by cytokines

1 reference

12 December 2020

Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes

1 reference

12 December 2020

Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings

1 reference

12 December 2020

The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells

1 reference

12 December 2020

Phase II study of mifepristone (RU486) in refractory ovarian cancer

1 reference

12 December 2020

Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells.

1 reference

12 December 2020

Effects of corticosteroid use on treatment of solid tumours

1 reference

12 December 2020

Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.

1 reference

12 December 2020

The influence of corticoid steroids on the frequency of spleen metastases in patients with breast cancer

1 reference

12 December 2020

[Corticosteroid therapy in bronchial carcinoma and other malignant tumors in the thorax]

1 reference

12 December 2020

Adrenal steroids and the pattern of metastases of breast cancer

1 reference

12 December 2020

TREATMENT OF PRIMARY CARCINOMA OF THE LIVER WITH NITROGEN MUSTARD AND PREDNISOLONE: REORT OF 51 CASES

1 reference

12 December 2020

Interference of glucocorticoids with apoptosis signaling and host-tumor interactions

1 reference

12 December 2020

Glucocorticoid administration in antiemetic therapy: is it safe?

1 reference

12 December 2020

Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas.

1 reference

12 December 2020

Glucocorticosteroid receptors in ovarian carcinomas.

1 reference

12 December 2020

Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis

1 reference

12 December 2020

Dexamethasone-dependent versus -independent markers of epithelial to mesenchymal transition in primary hepatocytes

1 reference

12 December 2020

The role of the fallopian tube in ovarian cancer.

1 reference

12 December 2020

10.1007/S12672-017-0319-0

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018